TGen
Science That Drives Economic Growth
The Challenge
As Arizona’s bioscience ecosystem evolved, TGen needed an updated assessment that captured its transformation from an anchor research institution into a driver of commercialization, job creation, and economic growth. The challenge was to clearly quantify TGen’s expanding economic, workforce, and public-sector impact while demonstrating how translational science and spin-off activity were strengthening Arizona’s competitiveness in precision medicine and advanced healthcare.
How We Helped
Tripp Umbach conducted a FY25 statewide economic impact study examining TGen’s core operations, Arizona-based spin-off companies, and in-state research collaborators. Building on nearly two decades of longitudinal analysis, the study quantified economic output, employment, and tax revenue, compared FY25 results to FY20, and incorporated TGen’s broader contributions to public health, workforce development, and health equity. Conservative projections of future impact through FY35 were also developed.
The Impact
The FY25 findings show that TGen has moved from “Promises Kept” to “Promises Exceeded.” TGen generated more than $1 billion in statewide economic impact in FY25, an increase of over 50% since FY20—with spin-offs and commercialization now accounting for roughly two-thirds of total impact. TGen-supported activity sustained 8,107 high-skill, high-wage jobs and generated more than $40 million in state tax revenue, returning $8 for every $1 invested by the State of Arizona.
Beyond economics, TGen advances precision medicine, public health intelligence, and health equity across Arizona. Looking ahead, TGen’s annual economic impact is conservatively projected to reach $1.6–$2.1 billion by FY35, positioning the institute for continued growth in innovation, workforce development, and statewide impact.